Oncology Billing Services
High-cost cancer treatments demand high-precision billing. One incorrect HCPCS unit, missing JW/JZ modifier, or chemotherapy administration code can put substantial reimbursement at risk.
Steady Medical Billing equips oncology providers and infusion practices with drug-unit reconciliation, NDC validation, denial prevention, and aggressive A/R follow-up to secure accurate payments and keep oncology revenue moving.
Your Oncology Practice Delivers High-Value Treatments. Why Are Payers Holding Back Your Revenue?
A single chemotherapy encounter can involve multiple drug J-codes, infusion administration codes, discarded drug units, and strict payer authorization rules. When NDC quantities don't match billed HCPCS units, infusion start-and-stop times are poorly documented, or treatment regimens change after authorization, even high-value claims face denials, downcoding, and underpayments.
Meanwhile, oncologists and hematologists are left managing expensive drug acquisition costs while thousands in reimbursements remain tied up in unresolved A/R. What overwhelms oncology practices isn't just the volume of claims; it's the constant pressure to fund costly therapies while chasing payments for treatments already delivered.
Turn Every Billable Oncology Treatment Into a Stronger Revenue Opportunity
At Steady Medical Billing, we go beyond basic claim submission with specialized Hematology oncology billing services built around the financial complexities of cancer care.
Our team manages chemotherapy and immunotherapy coding, J-code-to-NDC reconciliation, infusion administration hierarchies, JW/JZ modifiers, authorization verification, and payer-specific denial appeals to help protect reimbursements on high-cost treatments.
From complex Hematology billing for blood disorders to recovering underpaid oncology drug claims, we help your practice close revenue gaps, shorten payment cycles, and collect more of what you've legitimately earned.
High-Cost Cancer Treatments Deserve High-Precision Billing Solutions
Steady Medical Billing tackles the coding complexities, drug reimbursement discrepancies, and payer restrictions that put oncology revenue at risk. Every stage of the billing process is designed to protect high-cost treatment claims, prevent avoidable denials, and accelerate collections for oncologists, hematologists, and infusion centers.
Chemotherapy & Immunotherapy Coding
Accurate CPT coding for chemotherapy administration, immunotherapy infusions, and sequential drug delivery ensures proper reporting of treatment services while preventing missed charges and coding conflicts.
J-Code & NDC Unit Reconciliation
Detailed matching of HCPCS J-code units, administered drug quantities, and 11-digit NDC information helps prevent dosage discrepancies, rejected claims, and costly reimbursement shortfalls.
Infusion Hierarchy & Time-Based Coding
Careful validation of infusion start-and-stop times, initial administration codes, sequential infusions, and concurrent therapies captures eligible services without triggering coding hierarchy violations.
JW/JZ Modifier & Drug Waste Billing
Precise reporting of discarded drug quantities, single-dose vial usage, and applicable JW/JZ modifiers supports compliant reimbursement for eligible unused oncology medications.
Prior Authorization Management
Verification of regimen-specific approvals, authorized drug units, treatment cycles, and payer requirements helps prevent denials when chemotherapy protocols change or authorizations expire.
Medical Necessity & Diagnosis Validation
Alignment of ICD-10-CM cancer diagnoses, treatment indications, and payer coverage policies helps substantiate chemotherapy, biologic therapy, and supportive-care drug claims.
Oncology Denial Recovery
Targeted investigation of denied antineoplastic drug claims, infusion coding disputes, and payer underpayments supports stronger appeals and recovery of eligible outstanding reimbursements.
Drug Reimbursement Optimization
Review of payer contracts, drug-specific reimbursement methodologies, and underpaid HCPCS claims helps identify payment discrepancies and protect margins on expensive cancer therapies.
You've Already Delivered the Treatment. Now Get the Reimbursement You Deserve.
High-cost chemotherapy drugs and complex infusion procedures shouldn't leave your practice waiting months for payment. Steady Medical Billing tackles denied claims, underpaid J-codes, and unresolved oncology A/R to help accelerate collections and strengthen your cash flow.
From Medical Oncology to Radiation Therapy, Your Specialty Deserves Billing That Fits
At Steady Medical Billing, specialty-focused RCM solutions address the distinct documentation, coding, and reimbursement requirements of cancer care providers, helping practices protect revenue without adding administrative strain.
Medical Oncology Billing
Navigate chemotherapy administration, immunotherapy, targeted treatments, and high-cost injectable drug claims with precise coding and payer-specific reimbursement management.
Hematology-Oncology Billing
Simplify billing for blood cancers, chemotherapy regimens, transfusion services, and complex hematologic conditions with accurate diagnosis-to-procedure coding.
Radiation Oncology Billing
Manage treatment planning, simulation, dosimetry, image guidance, and radiation delivery claims with careful attention to applicable CPT codes and payer requirements.
Gynecologic Oncology Billing
Address the billing complexities of cancer-related surgical procedures, treatment encounters, and postoperative care while minimizing coding conflicts and reimbursement delays.
Surgical Oncology Billing
Support accurate reporting of tumor resections, lymph node procedures, surgical modifiers, and global-period services to protect eligible surgical reimbursements.
Pediatric Oncology Billing
Navigate age-specific treatment protocols, complex drug administration, and payer coverage requirements for pediatric cancer care.
Oncology Infusion Center Billing
Capture eligible infusion administration services, therapeutic injections, drug units, and treatment-related supplies through detailed charge reconciliation.
Bone Marrow Transplant Billing
Address the documentation and coding requirements associated with hematopoietic stem cell transplantation, cell collection, processing, and related services.
Different Cancer Treatments. Different Billing Rules. One Specialized RCM Partner
Not every cancer treatment follows the same reimbursement pathway. A chemotherapy infusion, radiation therapy session, and oral targeted therapy prescription can involve entirely different coding structures, coverage policies, and payment responsibilities.
Steady Medical Billing helps oncology practices navigate treatment-specific billing requirements so eligible services are accurately represented and reimbursement opportunities aren't overlooked.
Chemotherapy Administration
Specialized Billing SupportAccurate reporting of administration codes, infusion duration, sequential services, and eligible drug charges.
Immunotherapy Treatments
Specialized Billing SupportDrug-specific HCPCS coding, treatment documentation review, and applicable payer coverage verification.
Targeted Cancer Therapies
Specialized Billing SupportDiagnosis alignment, drug identification, dosage validation, and reimbursement requirements for targeted agents.
Radiation Therapy
Specialized Billing SupportCoding support for simulation, treatment planning, dosimetry, image guidance, and radiation delivery services.
Hormonal Cancer Treatments
Specialized Billing SupportAccurate billing for covered therapeutic injections, administered medications, and associated treatment services.
Supportive Cancer Care
Specialized Billing SupportBilling support for antiemetics, growth factors, hydration, and other medically necessary supportive treatments.
Therapeutic Injections
Specialized Billing SupportAppropriate administration coding, drug-unit reporting, and modifier validation for eligible injectable therapies.
When Cancer Drugs Cost Thousands, Every Reimbursement Detail Matters
Your practice purchases expensive oncology medications long before insurers reimburse their administration. When drug acquisition costs rise, payer allowances fall short, or payments arrive late, even a busy infusion center can experience serious cash flow pressure.
The real financial risk isn't always a denied claim. Sometimes, it's a paid claim that reimburses less than it should.
Protect the Margins Behind Every Oncology Drug
Buy-and-Bill Revenue Protection
High-cost injectable therapies create significant upfront expenses for oncology practices. Drug-level reimbursement reviews help identify payment discrepancies that could reduce margins on physician-administered medications.
ASP-Based Reimbursement Monitoring
Medicare Part B and certain commercial contracts use Average Sales Price-based methodologies. Comparing expected allowances against actual payments helps uncover reimbursement variances that deserve further investigation.
Drug Acquisition Cost Visibility
Understanding the relationship between medication purchase costs and payer reimbursement is essential for financial planning. Drug-specific payment analysis helps identify therapies with narrowing reimbursement margins.
Payer Contract Underpayment Detection
A processed claim doesn't necessarily mean accurate reimbursement. Contract-based payment reviews help identify incorrect allowances, pricing discrepancies, and potentially recoverable underpayments.
High-Cost Drug Payment Tracking
Expensive oncology medications can create substantial outstanding balances. Monitoring unpaid drug claims separately helps practices prioritize financially significant accounts before payment delays strain working capital.
Don't Let Your Most Expensive Treatments Become Your Biggest Financial Liability
Steady Medical Billing helps oncology providers identify reimbursement discrepancies, investigate underpaid drug claims, and pursue eligible payments.
Protect the financial value of your treatments while keeping more working capital available for patient care.
Medicare Oncology Billing Is Complicated. Your Reimbursements Don't Have to Be
Medicare oncology reimbursement requires more than selecting the correct procedure code. Coverage policies, drug payment methodologies, documentation requirements, and claim edits can determine whether a treatment is reimbursed accurately, reduced, or denied.
Steady Medical Billing supports oncology practices in navigating applicable Medicare billing requirements while reducing preventable claim discrepancies.
Medicare Part B Drug Claims
Validate applicable HCPCS codes, billable units, and drug administration charges against current Medicare requirements to support accurate reimbursement for covered physician-administered medications.
National and Local Coverage Policies
Review relevant National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) to identify diagnosis, documentation, and medical necessity requirements affecting oncology services.
Medically Unlikely Edits (MUEs)
Identify unit-of-service discrepancies and applicable claim-edit limitations before submission, reducing avoidable processing problems involving high-dose therapies and complex procedures.
Discarded Drug Reporting Requirements
Apply JW and JZ modifiers where required, with supporting documentation of administered and discarded quantities for applicable separately payable single-dose medications.
Medicare Claim Documentation
Review treatment records, physician orders, drug administration details, and supporting clinical information to substantiate billed services when documentation is requested.
Medicare Reimbursement Verification
Compare processed payments against applicable Medicare fee schedules and drug payment rates to identify discrepancies requiring correction or follow-up.
Keep Your Oncology Workflow. Upgrade Your Revenue Cycle
Your Clinical Team Stays Focused on Treatment
Physicians and nurses continue documenting chemotherapy administration, treatment plans, medication doses, and patient encounters within established clinical workflows.
Billing Requirements Connect With Clinical Documentation
Charge capture and documentation review processes help identify missing information before claims move through the revenue cycle.
Existing Practice Management Systems Remain Central
Billing workflows can be assessed for compatibility with your current EHR and practice management software, subject to system capabilities, access permissions, and integration requirements.
Outstanding Claims Don't Get Left Behind
During a billing transition, historical A/R, unresolved denials, open claims, and payer follow-ups can be reviewed to establish clear ownership and reduce the risk of overlooked balances.
Oral Cancer Therapies Need More Than Traditional Medical Billing
An oral cancer medication may never enter your infusion suite, but its reimbursement requirements can still create significant administrative challenges.
Oral chemotherapy and targeted therapies often follow different coverage and dispensing pathways than physician-administered oncology drugs. Depending on the medication, insurance plan, and treatment setting, coverage may fall under a pharmacy benefit or an applicable medical benefit.
For oncology practices managing oral treatment regimens, understanding these distinctions is essential to avoiding unnecessary coverage delays and administrative complications.
Where Oral Oncology Reimbursement Gets Complicated
Medical vs. Pharmacy Benefit Determination
Identifying the applicable coverage pathway helps prevent incorrect billing expectations and unnecessary claim routing.
Specialty Pharmacy Coordination
Treatment initiation may depend on prescription processing, dispensing requirements, and communication between the oncology practice, payer, and specialty pharmacy.
Drug-Specific Coverage Restrictions
Certain oral antineoplastic medications require additional clinical documentation, formulary review, or step-therapy considerations before coverage approval.
Patient Cost-Sharing Verification
High deductibles, coinsurance, and specialty-tier pharmacy benefits can create substantial patient financial obligations that require early identification.
Coverage Changes During Treatment
Dose adjustments, treatment substitutions, and insurance changes may require updated benefit verification or authorization.
Is Your In-House Oncology Billing Team Costing More Than It Collects?
Hiring billing staff is only the beginning. Your practice must also account for specialty coding expertise, ongoing payer policy changes, employee turnover, software expenses, claim follow-up capacity, and the financial consequences of unresolved reimbursement problems.
Why Choose Steady Medical Billing?
You've Invested in Cancer Care. Now Stop Letting Billing Gaps Put That Investment at Risk.
Every unresolved oncology claim, overlooked drug charge, and payer underpayment represents revenue your practice may be entitled to collect. Partner with Steady Medical Billing to uncover costly billing gaps, strengthen reimbursement accuracy, and put your oncology revenue cycle on a more profitable path.
Get My Free Oncology Billing Assessment